-+ 0.00%
-+ 0.00%
-+ 0.00%

Takeda Pharmaceutical continued to rise on the Tokyo Stock Exchange as the U.S. FDA granted priority review for its skin disease drug.

NIKKEI QUICK·09/15/2026 05:31:03

Please log in to view news